MediFind
Condition

Light Chain Deposition Disease

Active Clinical Trials

Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 36
  • Start Date: March 2013
Phase I Study of Pomalidomide, Bortezomib, and Dexamethasone (PVD) as First-Line Treatment of AL Amyloidosis or Light Chain Deposition Disease